Skip to main content
Signal8

Bradner James E.

SEC insider (Form 3/4/5 filer). CIK 0002005159. EVP, Research and Development at AMGEN INC (AMGN). 6 reported Form 4/5 transactions since Sep 2024; latest on May 7, 2026. Located in THOUSAND OAKS, CA.

Companies Bradner James E. has filed insider reports for

  • AMGEN INC (AMGN): Officer, EVP, Research and Development
Bradner James E. profile photo

Bradner James E.

CIK: 0002005159

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (33.3%)

Compensation grants

Other (G, F, J, C, D, …)4 (66.7%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

AMGEN INC logo
AMGN

AMGEN INC

Officer

Discretionary Trading P&L

Holdings

Transaction History (6 total)

  • AMGEN INC logo
    AMGN

    AMGEN INC

    May 7, 2026
    Tax Payment
    Direct
    446 shares at avg. $331.11$148K
  • AMGEN INC logo
    AMGN

    AMGEN INC

    May 6, 2026
    Tax Payment
    Direct
    407 shares at avg. $329.59$134K
  • AMGEN INC logo
    AMGN

    AMGEN INC

    May 5, 2026
    Award
    Direct
    3.3K shares-
  • AMGEN INC logo
    AMGN

    AMGEN INC

    Feb 9, 2026
    Tax Payment
    Direct
    2.2K shares at avg. $384.32$827K
  • AMGEN INC logo
    AMGN

    AMGEN INC

    Feb 9, 2026
    Tax Payment
    Direct
    953 shares at avg. $384.32$366K
  • AMGEN INC logo
    AMGN

    AMGEN INC

    May 6, 2025
    Award
    Direct
    3.5K shares-

1-6 of 6